• Source of omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health
• Helps support cognitive health and brain function
• Helps support the development of the brain, eyes and nerves in children up to 12 years of age

MaxSimil® Patented Lipid Absorption Enhancement Technology (PLATform) The MaxSimil PLATform is a novel monoglyceride delivery system that enhances absorption of lipid-based and lipid-soluble nutraceutical and food ingredients. This technology has been applied to XYMOGEN’s Omega MonoPure formulas in order to create a unique vehicle by which to deliver EPA and DHA.

Manufactured using MaxSimil® fish oil. MaxSimit® is a registered trademark of Ingenutra Inc. Protected under US patents 8,119,690 and 8,198,324; Canadian patents 2672513 and 2677670.

Exp: 12/2026

Supplement Facts

Medicinal Ingredients (per softgel)

MaxSimil® Fish oil (Engraulidae - Whole, Clupeidae - Whole): 1.3 g

600 mg eicosapentaenoic acid (EPA)

260 mg docosahexaenoic acid (DHA)

860 mg Omega-3 Fatty acids

Non-Medicinal Ingredients

Gelatin, glycerin, purified water, ethylcellulose, sodium alginate, medium chain triglycerides, oleic acid, stearic acid, ammonium hydroxide, mixed tocopherols concentrale.